Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dasatinib in Resectable Malignant Pleural Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00652574
Recruitment Status : Unknown
Verified September 2018 by M.D. Anderson Cancer Center.
Recruitment status was:  Active, not recruiting
First Posted : April 3, 2008
Last Update Posted : September 27, 2018
Sponsor:
Collaborators:
Bristol-Myers Squibb
United States Department of Defense
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 2019
Estimated Study Completion Date : March 2019